Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2014; 20(2): 525-531
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.525
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.525
Table 5 Univariate analysis of 5-year overall survival
| RFA (n = 17) | Resection (n = 12) | P-value | ||||
| 3-yr | 5-yr | 3-yr | 5-yr | |||
| Sex | Female | 42.9% | 42.9% | 100% | 100% | 0.083% |
| Male | 60.0% | 30.0% | 50.0% | 50.0% | 0.925% | |
| Age (yr) | ≤ 65 | 58.3% | 38.9% | 50.0% | 50.0% | 0.848% |
| > 65 | 40.0% | 40.0% | 75.0% | 75.0% | 0.187% | |
| Primary | 1-3 | 50.0% | 33.3% | 75.0% | 75.0% | 0.194% |
| T stage | 4 | 66.7% | 66.7% | 50.0% | 50.0% | 0.847% |
| Timing of | Synchronous | 33.3% | 33.3% | 100% | 100% | 0.093% |
| Metastasis | Metachronous | 63.6% | 42.4% | 55.6% | 55.6% | 0.975% |
| Preoperative chemotherapy | No | 50.0% | 50.0 | 66.7 | 66.7 | 0.410 |
| Yes | 54.5% | 36.4% | 66.7% | 66.7% | 0.495% | |
| Primary site | Colon | 50.0% | 37.5% | 75.0% | 75.0% | 0.202% |
| Rectum | 57.1% | 38.1% | 50.0% | 50.0% | 0.992% | |
| Metastatic | Negative Positive | 50.0% | 50.0% | 100% | 100% | 0.175% |
| Lymph node | 54.5% | 32.7% | 55.6% | 55.6% | 0.502% | |
| Lymphovascular invasion | Negative | 55.6% | 55.6% | 100% | 100% | 0.140% |
| Positive | 50.0% | 25.0% | 50.0% | 50.0% | 0.638% | |
| Perineural invasion | Negative Positive | 71.4% | 71.4% | 100% | 100% | 0.214% |
| 40.0% | 20.0% | 42.9% | 42.9% | 0.515% | ||
| Primary | ≤ 3 cm | 69.2% | 49.50% | 80.0% | 80.0% | 0.464% |
| Tumor size | > 3 cm | 0.0% | 0.0% | 57.1% | 57.1% | 0.005% |
| Postoperative chemotherapy | No | 20.0% | 20.0% | 0.0% | 0.0% | 0.929% |
| Yes | 66.7% | 47.6% | 80.0% | 80.0% | 0.341% | |
- Citation: Ko S, Jo H, Yun S, Park E, Kim S, Seo HI. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol 2014; 20(2): 525-531
- URL: https://www.wjgnet.com/1007-9327/full/v20/i2/525.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i2.525